• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORPORATION GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORPORATION GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Model Number 00-1111-001-00
Device Problem Insufficient Information (3190)
Patient Problem Spinal Column Injury (2081)
Event Type  Injury  
Manufacturer Narrative
This concerned lot number was not available, however we regard it as 0019x22g or 0019x23g from the reported expiration date.Those lot number were delivered in the u.S.In december 2019.We attempt to contact the reporter for the details through our us partner.
 
Event Description
On (b)(6): a (b)(6) year-old female patient received gel-one injection into the knees for osteoarthritis.The reported pharmacy shipped gel-one on 2020-04-06.On (b)(6) 2020: the patient had 2 emergency back surgeries this month.
 
Manufacturer Narrative
This is a definitive report.H6 and h10 were updated.According to our us partner on (b)(6) 2020, no additional information was available in contact attempts on (b)(6).This concerned lot number was not available, however we regard it as 0019x22g or 0019x23g from the reported expiration date.Those lot number were delivered in the u.S.In (b)(6) 2019.According to the result of investigation, there were no deviations or out-of-specifications found in the manufacturing process, the in-process testing, the release testing, and the environmental monitoring for lot# both 0019x22g and 0019x23g.We selected the code of 4316 (appropriate term/code not available) for h.6 manufacturer evaluation conclusion code, because the reported adverse event was not listed in the package insert and concerned lot number was not available.
 
Event Description
2020-unk: a (b)(6) female patient received gel-one injection into the knees for osteoarthritis.The reported pharmacy shipped gel-one on (b)(6) 2020.(b)(6) 2020 unk: the patient had 2 emergency back surgeries this month.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORPORATION
marunouchi center building
6-1, marunouchi 1-chome
chiyoda-ku, tokyo 100-0 005
JA  100-0005
MDR Report Key10111342
MDR Text Key195533833
Report Number9612392-2020-00007
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
PMA/PMN Number
P080020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 05/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/01/2020
Device Model Number00-1111-001-00
Device Catalogue Number00-1111-001-00
Was Device Available for Evaluation? No
Date Manufacturer Received07/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age50 YR
-
-